Dennis BB, Bowles J, Johnson C, De Wolfe T, Mundel E, Fast D, Boyd J, Fleury M, Bach P, Fairbairn N, Socías ME, Ti L, Hayashi K, DeBeck K, Milloy MJ, Felicella G, Morgan J, Eekhoudt CR, McGrail K, Richardson L, Ryan A, Mbuagbaw L, Guyatt G, Nolan S Road to Recovery: protocol for a mixed-methods prospective cohort study evaluating the impact of a new model of substance use care in a Canadian setting BMJ Open PubMed

Lakkadghatwala R, Lane D, Scheuermeyer F, Hilburt J, Buxton J, Johnson C, Nolan S, Sutherland C, Moe J, Daoust R, Dong K, Christenson J, Miles I, Orkin A, Whyte M, Kestler A An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study Subst Abuse Treat Prev Policy PubMed

Duncan K, Scheuermeyer F, Lane D, Ahamad K, Moe J, Dong K, Nolan S, Buxton J, Miles I, Johnson C, Christenson J, Whyte M, Daoust R, Garrod E, Badke K, Kestler A Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs CJEM PubMed

Mitra S, Choi JC, van Draanen J, Kerr T, Gilbert M, Hayashi K, Milloy MJ, Johnson C, Richardson L Socioeconomic marginalization and risk of overdose in a community-recruited cohort of people who use drugs: a longitudinal analysis Int J Drug Policy PubMed

Socías ME, Choi JC, Fairbairn N, Johnson C, Wilson D, DeBeck K, Brar R, Hayashi K Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: an interrupted time series analysis Int J Drug Policy PubMed

Moallef S, DeBeck K, Fairbairn N, Cui Z, Brar R, Wilson D, Johnson C, Milloy MJ, Hayashi K Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy Addict Sci Clin Pract PubMed

Norton A, Hayashi K, Johnson C, Choi JC, Milloy MJ, Kerr T Injecting drugs alone during an overdose crisis in Vancouver, Canada Harm Reduct J PubMed

Weng J, Fairbairn N, Sutherland C, Johnson C, Nolan S Supervised Tablet injectable Opioid Agonist Therapy (TiOAT): a strategy to address safer supply for individuals with an opioid use disorder? J Addict Med PubMed

McWilliams C, Bonnie K, Robinson S, Johnson C, Puyat JH, Klimas J Preliminary results of psychiatric inpatients referred to an addiction medicine consult service J Addict Med PubMed

Karamouzian M, Johnson C, Kerr T Public health messaging and harm reduction in the time of COVID-19 Lancet Psychiatry PubMed